68
46
Growth Score 68 in past quarter
-14 pts
Heat Score 46 in past quarter
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
642138
Nanolek is a biopharmaceutical company that develops and supplies substituting medicines for the prevention and treatment of diseases.
- Artem An: Deputy CEO
About the Company
Nanolek is a Russian biopharmaceutical company with high-quality full-cycle production GMP standards that specializes in developing import-substituting drugs focusing on prophylactic and treatment of socially significant diseases along with localization of the drugs of global pharmaceutical companies.
